Gene: [19q133/CKM] creatine kinase, muscle form;


  • Gene: [05q133/CKMT2] creatine kinase, mitochondrial 2 (sarcomeric);
  • Gene: [14q323/CKB] creatine kinase, brain form;
  • Gene: [15q15/CKMT1] creatine kinase, mitochondrial 1 (ubiquitous);
  • Gene: [19q131/RYR1] ryanodine receptor 1 (skeletal muscle; calcium release channel); Ca++ release channel of sarcoplasmic reticulum; malignant hyperthermia susceptibility 1 (King syndrome; MHS1; MIM:145600); central core disease of muscle (
  • Gene: [19q132/APOC1P1] apolipoprotein C-I pseudogene 1;
  • Gene: [19q132/APOC1] apolipoprotein C-I;
  • Gene: [19q132/APOC2] apolipoprotein C-II (lipoprotein lipase activator); lipase D activator (apolipoprotein C-II); hyperlipoproteinemia, type I-B (C-II anapolipoproteinemia);
  • Gene: [19q132/APOE] apolipoprotein E; hyperlipoproteinemia, type III; [APOE1 HPL3 ]
  • Gene: [19q132/ATP1A3] ATPase, Na+,K+ transporting, alpha 3 polypeptide;
  • Gene: [19q132/BCL3] B-cell chronic lymphatic leukemia 3 (B-CLL: lymphoma 3); [BCL4 D19S37 ]
  • Gene: [19q132/CYP2A6] cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6; coumarin 7-hydroxilase (microsomal; cytochrome P450-IIA3; MIM:122720);
  • Gene: [19q133/DMPK] myotonic distrophy protein kinase; dystrophia myotonia;
  • Gene: [19q133/ERCC1] excision repair cross-complementing rodent repair deficiency, complementation group 1; [UV20 ]
  • Gene: [19q133/ERCC2] excision repair cross-complementing rodent repair deficiency, complementation group 2; xeroderma pigmentosum, complementation group D (MIM:278730); trichothiodystrophy (ichthyosiform erytroderma) (MIM:601675); [XPD TTD
  • Gene: [19q134/PRKCG] protein kinase C, gamma polypeptide;
  • HUGEN- MM
  • (MCK)